Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
The Clinical Investigator
|
September 1, 1992
Autosomal dominant polycystic kidney disease: from molecular genetics to the patients
J P Grünfeld, D Chauveau, B Knebelmann
Cancer Research
|
January 27, 1998
Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor
B Knebelmann, S Ananth, H T Cohen, et al.
Molecular and Cellular Biology
|
September 1, 1997
The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity
D Mukhopadhyay, B Knebelmann, H T Cohen, et al.
Trends in Endocrinology and Metabolism: TEM
|
November 1, 1991
Anti-Müllerian hormone and intersex states
N Josso, L Boussin, B Knebelmann, et al.
Kidney International
|
June 8, 2007
Collagen alpha5 and alpha2(IV) chain coexpression: analysis of skin biopsies of Alport patients
N Patey-Mariaud de Serre, M Garfa, B Bessiéres, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1991
Anti-Müllerian hormone Bruxelles: a nonsense mutation associated with the persistent Müllerian duct syndrome
B Knebelmann, L Boussin, D Guerrier, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 2, 2001
Granulomatous renal disease in a patient with common variable immunodeficiency
F Fakhouri, C Robino, M Lemaire, et al.
Cancer Research
|
May 8, 1999
Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma
S Ananth, B Knebelmann, W Grüning, et al.
The Journal of Biological Chemistry
|
April 17, 1999
Endostatin induces endothelial cell apoptosis
M Dhanabal, R Ramchandran, M J Waterman, et al.
Annales D'Endocrinologie
|
January 1, 1991
[Molecular biology of normal and pathologic anti-müllerian hormone]
S Imbeaud, D Carre-Eusebe, L Boussin, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
The Clinical Investigator
|
September 1, 1992
Autosomal dominant polycystic kidney disease: from molecular genetics to the patients
J P Grünfeld, D Chauveau, B Knebelmann
Cancer Research
|
January 27, 1998
Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor
B Knebelmann, S Ananth, H T Cohen, et al.
Molecular and Cellular Biology
|
September 1, 1997
The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity
D Mukhopadhyay, B Knebelmann, H T Cohen, et al.
Trends in Endocrinology and Metabolism: TEM
|
November 1, 1991
Anti-Müllerian hormone and intersex states
N Josso, L Boussin, B Knebelmann, et al.
Kidney International
|
June 8, 2007
Collagen alpha5 and alpha2(IV) chain coexpression: analysis of skin biopsies of Alport patients
N Patey-Mariaud de Serre, M Garfa, B Bessiéres, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1991
Anti-Müllerian hormone Bruxelles: a nonsense mutation associated with the persistent Müllerian duct syndrome
B Knebelmann, L Boussin, D Guerrier, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 2, 2001
Granulomatous renal disease in a patient with common variable immunodeficiency
F Fakhouri, C Robino, M Lemaire, et al.
Cancer Research
|
May 8, 1999
Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma
S Ananth, B Knebelmann, W Grüning, et al.
The Journal of Biological Chemistry
|
April 17, 1999
Endostatin induces endothelial cell apoptosis
M Dhanabal, R Ramchandran, M J Waterman, et al.
Annales D'Endocrinologie
|
January 1, 1991
[Molecular biology of normal and pathologic anti-müllerian hormone]
S Imbeaud, D Carre-Eusebe, L Boussin, et al.
Page
of 3